Press Releases Items Per Page 102550 News Category FinancialGeneral Year None202320222021202020192018201720162015201420132012201120102009200820072006 Advisory: Nektar Sets Announcement Date and Conference Call for the Year and Fourth Quarter 2005 Feb 21, 2006 Nektar Announces That U.S. FDA Has Granted Orphan Drug Designation to the First Amphotericin B Inhalation Powder to Prevent Pulmonary Fungal Infections in Immunosuppressed Patients Feb 14, 2006 2006 Deutsche Bank Small Cap Growth Conference to Webcast Nektar Corporate Presentation Feb 10, 2006 Advisory: BIO CEO and Investor Conference to Webcast Nektar Corporate Presentation Feb 09, 2006 Nektar CEO to Retire; Executive Chairman Appointed Acting CEO Feb 07, 2006 Merrill Lynch to Webcast Nektar Corporate Presentation Feb 01, 2006 Pfizer Receives FDA Approval for Exubera, the First Inhaleable Form of Insulin for Controlling Type 1 and Type 2 Diabetes in Adults Jan 27, 2006 European Commission Approves Exubera(R) (Inhaled Human Insulin) for Treatment of Type 1 and Type 2 Diabetes Jan 26, 2006 Nektar Therapeutics Appoints New Chief Financial Officer Jan 19, 2006 Nektar Reports Pfizer to Acquire the Sanofi-Aventis Worldwide Rights to Exubera® (Inhaled Human Insulin) Jan 13, 2006 Pagination First page « first Previous page ‹ previous … Page 45 Page 46 Page 47 Page 48 Page 49 Page 50 Page 51 Page 52 Current page 53